Enamine Ltd., a provider of drug discovery services leveraging large collections of building blocks and screening compounds, and H. Lundbeck, a global pharmaceutical company researching new drugs for the treatment of central nervous system disorders, have expanded their research collaboration. Enamine will support Lundbeck’s in-house discovery chemistry competencies with three principal assets enabling Lundbeck to optimally identify and develop hit series in its multiple research programs.   L...